Sustained delivery therapies have the potential to reshape retinal disease management, but are misconceptions about their risks, benefits, and real-world performance holding you back? This Mythbusters activity separates fact from fiction, equipping retina specialists and other ophthalmologists to move beyond assumptions and toward evidence-based decision-making. Experts will directly address common myths surrounding sustained delivery strategies, clarifying patient eligibility, durability, safety, and clinical application versus the standard of care. Don t let outdated thinking limit your patients outcomes; join us to align your practice with current data.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Pricing
97% of listed courses are free
34 of 35 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Communication & Shared Decision-Making
- Dermatology
- Gastroenterology
- General Pediatrics
- Hematology
- Medical Oncology
- Nephrology
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Psychotic Disorders
- Rheumatology
- Surgical Oncology
- Cross-Specialty
- GI & Liver
- Medical Subspecialties
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Pediatrics
- Psychiatry
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedOct 2, 2026
-
Last day to claim creditOct 3, 2027 12 months left
-
PRIME Education, Inc. (PRIME®) Beyond Intravitreal Injections: Advancing Retinal Vascular Disease Care With Sustained Delivery Therapies
-
Vindico Medical Education, LLC nAMD, DME, and MacTel: Innovations in Sustained Delivery
-
Multiple Myeloma Research Foundation (MMRF) +1 Clinical Pearls for Subcutaneous Delivery: Optimizing Anti-CD38 Delivery in Multiple Myeloma
-
Paradigm Medical Communications, LLC Delivering on the Promise of Sustained Treatment: Innovations in Long-Term Disease Control
-
Paradigm Medical Communications, LLC Reading Between the Lines: Nuanced Decision-Making With Sustained Delivery Therapies
-
Paradigm Medical Communications, LLC Moving Beyond Injection Burden: Breakthroughs in Sustained Retinal Delivery
